Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study
Openalex
Resumen
Instituto de Salud Carlos III, Fundació Bancaria La Caixa, Fundació La Marató de TV3, Medical Research Council, and National Institutes of Health.
Cómo citar
Juan Fortea, & Eduard Vilaplana, & María Carmona‐Iragui, & Bessy Benejam, & Laura Videla, & Isabel Barroeta, & Susana Fernández, & Miren Altuna, & Jordi Pegueroles, & Víctor Montal, & Sílvia Valldeneu, & Sandra Giménez, & Sofía González‐Ortiz, & Laia Muñoz, & Teresa Estellés, & Ignacio Illán‐Gala, & Olivia Belbin, & Valle Camacho, & Liam R. Wilson, & Tiina Annus, & Ricardo S. Osorio, & Sebastián Videla, & Sylvain Lehmann, & Anthony Holland, & Daniel Alcolea, & Jordi Clarimón, & Shahid Zaman, & Rafael Blesa, & Alberto Lleó (2020). Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. https://doi.org/10.1016/s0140-6736(20)30689-9